1. Home
  2. TGLS vs AAPG Comparison

TGLS vs AAPG Comparison

Compare TGLS & AAPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tecnoglass Inc.

TGLS

Tecnoglass Inc.

HOLD

Current Price

$39.45

Market Cap

1.8B

ML Signal

HOLD

AAPG

Ascentage Pharma Group International American Depository Shares

HOLD

Current Price

$19.45

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TGLS
AAPG
Founded
1984
2009
Country
United States
China
Employees
N/A
767
Industry
Electronic Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.8B
2.0B
IPO Year
2011
N/A

Fundamental Metrics

Financial Performance
Metric
TGLS
AAPG
Price
$39.45
$19.45
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$63.33
$48.40
AVG Volume (30 Days)
309.6K
4.3K
Earning Date
05-07-2026
05-20-2026
Dividend Yield
1.41%
N/A
EPS Growth
N/A
N/A
EPS
0.71
N/A
Revenue
$370,984,000.00
N/A
Revenue This Year
$13.56
$290.34
Revenue Next Year
$9.04
N/A
P/E Ratio
$54.41
N/A
Revenue Growth
17.98
N/A
52 Week Low
$37.52
$19.11
52 Week High
$90.34
$48.45

Technical Indicators

Market Signals
Indicator
TGLS
AAPG
Relative Strength Index (RSI) 42.36 29.60
Support Level N/A N/A
Resistance Level $46.89 $25.23
Average True Range (ATR) 2.05 0.57
MACD -0.28 -0.28
Stochastic Oscillator 20.29 14.99

Price Performance

Historical Comparison
TGLS
AAPG

About TGLS Tecnoglass Inc.

Tecnoglass Inc is a manufacturer of hi-spec architectural glass and windows for residential and commercial construction industries, operating through its direct and indirect subsidiaries. Its product offerings include tempered glass, laminated glass, thermo-acoustic glass, sliding windows, projecting windows, guillotine windows, sliding doors, loating facades, automatic doors, bathroom dividers, and commercial display windows, among others. The company has one operating segment, Architectural Glass and Windows, which is also its reporting segment. Geographically, the company generates maximum revenue from its customers in the United States, followed by Colombia, Panama, and other regions.

About AAPG Ascentage Pharma Group International American Depository Shares

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Share on Social Networks: